FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040803917> ?p ?o ?g. }

• W2040803917 endingPage "456" @default.
• W2040803917 startingPage "451" @default.
• W2040803917 abstract "Our clinic has fortuitously developed the therapeutic use of the association of mianserin (maximum daily dose 90 mg) and carbamazepine (maximum daily dose 400 mg) in opiate withdrawal management. If animal studies have suggested efficacy of mianserin in such indication, no human studies have been performed. To test the efficacy of such an association, a comparison was made to clonidine (maximum daily dose 0·600 mg) in a one week treatment period according to a double blind pilot study design. Thirty-two patients were included (16 in each treatment group). The two treatments did not differ in the intensity of the withdrawal, according to the rate of retention in treatment and symptoms, and the psychic distress which were auto-evaluated every other day with the Opiate Withdrawal Questionnaire and several Visual Analog Scales (VAS). The clonidine group, however, scored significantly higher (P<0·05) on the VAS rating of the global feeling of satisfaction on the last day. The patients in the mianserin group fortuitously had a moderately lower number of daily heroin intakes but there was no significant correlation between this variable and the global OWQ scores on Days 1, 3, 5 and 7. Given the size of the groups, we cannot conclude that the association carbamazepine-mianserin is as effective as clonidine, but a real effectiveness is probable. A study versus placebo would be necessary to draw more definitive conclusions." @default.
• W2040803917 created "2016-06-24" @default.
• W2040803917 creator A5007362090 @default.
• W2040803917 creator A5024084379 @default.
• W2040803917 creator A5026033159 @default.
• W2040803917 creator A5029845921 @default.
• W2040803917 creator A5041764955 @default.
• W2040803917 creator A5043965182 @default.
• W2040803917 creator A5057910388 @default.
• W2040803917 creator A5073250901 @default.
• W2040803917 creator A5078725452 @default.
• W2040803917 date "1997-05-01" @default.
• W2040803917 modified "2023-09-27" @default.
• W2040803917 title "THE ASSOCIATION CARBAMAZEPINE-MIANSERIN IN OPIATE WITHDRAWAL: A DOUBLE BLIND PILOT STUDY VERSUS CLONIDINE" @default.
• W2040803917 cites W1982264926 @default.
• W2040803917 cites W1984960813 @default.
• W2040803917 cites W1993215757 @default.
• W2040803917 cites W1998637335 @default.
• W2040803917 cites W2013579180 @default.
• W2040803917 cites W2016400806 @default.
• W2040803917 cites W2019720820 @default.
• W2040803917 cites W2029964069 @default.
• W2040803917 cites W2050344170 @default.
• W2040803917 cites W2055663366 @default.
• W2040803917 cites W2078603772 @default.
• W2040803917 cites W2103394537 @default.
• W2040803917 cites W2103520969 @default.
• W2040803917 cites W2109905455 @default.
• W2040803917 cites W2123150938 @default.
• W2040803917 cites W2127078387 @default.
• W2040803917 cites W2151756295 @default.
• W2040803917 cites W2153716482 @default.
• W2040803917 cites W2159650364 @default.
• W2040803917 cites W2407406545 @default.
• W2040803917 cites W3026564500 @default.
• W2040803917 doi "https://doi.org/10.1006/phrs.1997.0170" @default.
• W2040803917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9308074" @default.
• W2040803917 hasPublicationYear "1997" @default.
• W2040803917 type Work @default.
• W2040803917 sameAs 2040803917 @default.
• W2040803917 citedByCount "32" @default.
• W2040803917 countsByYear W20408039172012 @default.
• W2040803917 countsByYear W20408039172014 @default.
• W2040803917 countsByYear W20408039172015 @default.
• W2040803917 countsByYear W20408039172016 @default.
• W2040803917 countsByYear W20408039172018 @default.
• W2040803917 countsByYear W20408039172021 @default.
• W2040803917 countsByYear W20408039172023 @default.
• W2040803917 crossrefType "journal-article" @default.
• W2040803917 hasAuthorship W2040803917A5007362090 @default.
• W2040803917 hasAuthorship W2040803917A5024084379 @default.
• W2040803917 hasAuthorship W2040803917A5026033159 @default.
• W2040803917 hasAuthorship W2040803917A5029845921 @default.
• W2040803917 hasAuthorship W2040803917A5041764955 @default.
• W2040803917 hasAuthorship W2040803917A5043965182 @default.
• W2040803917 hasAuthorship W2040803917A5057910388 @default.
• W2040803917 hasAuthorship W2040803917A5073250901 @default.
• W2040803917 hasAuthorship W2040803917A5078725452 @default.
• W2040803917 hasConcept C118552586 @default.
• W2040803917 hasConcept C126322002 @default.
• W2040803917 hasConcept C14184104 @default.
• W2040803917 hasConcept C142724271 @default.
• W2040803917 hasConcept C15744967 @default.
• W2040803917 hasConcept C170493617 @default.
• W2040803917 hasConcept C204787440 @default.
• W2040803917 hasConcept C27081682 @default.
• W2040803917 hasConcept C2778140631 @default.
• W2040803917 hasConcept C2778186239 @default.
• W2040803917 hasConcept C2778399450 @default.
• W2040803917 hasConcept C2779177272 @default.
• W2040803917 hasConcept C2779253243 @default.
• W2040803917 hasConcept C2780831388 @default.
• W2040803917 hasConcept C42219234 @default.
• W2040803917 hasConcept C558461103 @default.
• W2040803917 hasConcept C71924100 @default.
• W2040803917 hasConceptScore W2040803917C118552586 @default.
• W2040803917 hasConceptScore W2040803917C126322002 @default.
• W2040803917 hasConceptScore W2040803917C14184104 @default.
• W2040803917 hasConceptScore W2040803917C142724271 @default.
• W2040803917 hasConceptScore W2040803917C15744967 @default.
• W2040803917 hasConceptScore W2040803917C170493617 @default.
• W2040803917 hasConceptScore W2040803917C204787440 @default.
• W2040803917 hasConceptScore W2040803917C27081682 @default.
• W2040803917 hasConceptScore W2040803917C2778140631 @default.
• W2040803917 hasConceptScore W2040803917C2778186239 @default.
• W2040803917 hasConceptScore W2040803917C2778399450 @default.
• W2040803917 hasConceptScore W2040803917C2779177272 @default.
• W2040803917 hasConceptScore W2040803917C2779253243 @default.
• W2040803917 hasConceptScore W2040803917C2780831388 @default.
• W2040803917 hasConceptScore W2040803917C42219234 @default.
• W2040803917 hasConceptScore W2040803917C558461103 @default.
• W2040803917 hasConceptScore W2040803917C71924100 @default.
• W2040803917 hasIssue "5" @default.
• W2040803917 hasLocation W20408039171 @default.
• W2040803917 hasLocation W20408039172 @default.
• W2040803917 hasOpenAccess W2040803917 @default.
• W2040803917 hasPrimaryLocation W20408039171 @default.
• W2040803917 hasRelatedWork W1974544446 @default.

• next